VCYT

Veracyte, Inc.

45.95

USD

+2.13

+4.85%

Sep 24, 12:47 UTC -4

Open

VCYT Earnings Reports

Positive Surprise Ratio

VCYT beat 31 of 43 last estimates.

72%

Next Report

Date of Next Report

Nov 02, 2026

Estimate for Q3 26 (Revenue/ EPS)

$150.39M

/

$0.42

Implied change from Q2 26 (Revenue/ EPS)

+0.04%

/

+35.48%

Implied change from Q3 25 (Revenue/ EPS)

+14.04%

/

+75.00%

Veracyte, Inc. earnings per share and revenue

On Jul 30, 2026, VCYT reported earnings of 0.31 USD per share (EPS) for Q2 26, beating the estimate of 0.26 USD, resulting in a 16.89% surprise. Revenue reached 150.32 million, compared to an expected 147.44 million, with a 1.95% difference. The market reacted with a -22.52% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 15 analysts forecast an EPS of 0.42 USD, with revenue projected to reach 150.39 million USD, implying an increase of 35.48% EPS, and increase of 0.04% in Revenue from the last quarter.

FAQ

What were Veracyte, Inc.'s earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Veracyte, Inc. reported EPS of $0.31, beating estimates by 16.89%, and revenue of $150.32M, 1.95% above expectations.

How did the market react to Veracyte, Inc.'s Q2 2026 earnings?

The stock price moved down -22.52%, changed from $59.78 before the earnings release to $46.32 the day after.

When is Veracyte, Inc. expected to report next?

The next earning report is scheduled for Nov 02, 2026.

What are the forecasts for Veracyte, Inc.'s next earnings report?

Based on 15 analysts, Veracyte, Inc. is expected to report EPS of $0.42 and revenue of $150.39M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.